Suppliers Innovative Research, Inc
Plasma collected from Kidney carcinoma patients. Samples are available as non-pooled 1 ml aliquots from individual cases.
Plasma collected from Liver carcinoma patients. Samples are available as non-pooled 1 ml aliquots from individual cases.
Plasma collected from Melanoma Patients. Samples are available as non-pooled 1 ml aliquots from individual cases
Plasma collected from Stage I to Stage III prostate carcinoma patients. Samples are available as non-pooled 1 ml aliquots from individual cases.
Plasma collected from Stage I rectum carcinoma patients. Samples are available as non-pooled 1 ml aliquots from individual cases.
Plasma collected from Testis carcinoma patients. Samples are available as non-pooled 1 ml aliquots from individual cases.
Plasma collected from Thyroid carcinoma patients. Samples are available as non-pooled 1 ml aliquots from individual cases.
Glycolyslated human PAI-1 produced in insect cells with a molecular weight of 46,000 Da. The stable mutant contains mutations to confer additional stability...
Glycosylated mouse PAI-1 produced in insect cells with a single conservative mutation (Isoleucine 91 to Leucine) to increase stability.
The Q123K point mutation on the human PAI-1 stable mutant background (K154T, Q319L, M354I and N150H) results in PAI-1 with a greatly extended half life and...
The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the...
The human form of PAI-1 contains the following four mutations: K154T, Q319L, M354I and N150H. These mutations combine to confer great stability to the...
A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been...
A patent pending mutant of human PAI-1 containing four mutations that stabilize the activity of PAI-1 has been made available. The N-terminus has been...
Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Active form.
Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Active form.
Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Latent form.
Glycosylated wild type human PAI-1 produced in insect cells with molecular weight of 46,000 Da. Latent form.
Stable mutant human PAI-1 biotin labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).
Stable mutant human PAI-1 biotin labeled by iodoacetamide substitution at the N-terminal cysteine (patent pending).
Get the Best Promotions
.gif?1376593640 "Biosave Filter")
